|

Publication

Sniffing, Snorting Drugs May Raise HCV Risk

by Theresa Waldron

Reuters Health 4 Jul. 2003

Source: Journal of Medical Virology. 2003;70:387-390.

People who snort or sniff heroin in combination with cocaine may be at increased risk of developing the liver infection hepatitis C, according to a new study.

Thomas Kresina, a spokesman for the National Institute on Drug Abuse in Bethesda, Maryland, which funded the study, said in an interview that any of the drugs might actually cause bleeding in the nose. HCV can be transmitted when

objects such as straws used to sniff or snort drugs are shared. “Obviously, the

more drugs you put in intranasally, the more you’re going to irritate your

(nasal) vascular wall, and that’s going to result in a little bleeding in the

nose,” he explained. “Then that blood goes on the instrument you use (to sniff or snort), and you transfer that to the next person. That’s where the risk

occurs.”

In the study of 276 people who had ever smoked crack or who sniffed or snorted cocaine or heroin, 4.7% were infected with HCV. Participants who sniffed or snorted heroin and cocaine together were most likely to be infected with HCV. The reason for the increased risk of HCV infection among those participants

may be related to the combined damaging effects of the drugs on the delicate

nasal mucosal lining.

Similar Posts

  • Month: May 2019

    Admin 08/08/2021

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • Myths About Methadone by Emmett Velten-2

    Admin 10/11/2022

    Not just in substance abuse, mental health, and AIDS services do methadone patients face routine discrimination.  San Francisco MUNI will not allow methadone patients to drive its buses, even though an important legal ruling in New York overturned a similar policy (Beazer vs New York City Transit Authority, 1975). Not just in those instances but…

  • Publication Index

    Admin 03/18/2022

    FOR IMMEDIATE RELEASE: October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 NIDA Research and SAMHSA Physician Training Combine to Put Care for Opiate Dependence in Hands of Family Doctor. Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA),…

  • NAMA Talk

    Admin 02/07/2022

    Volumn 2, Number 1 February 15, 2000 Organizational News by Joycelyn Woods The big news as this year and the Millennium closes is that methadone is slowly moving to being an accepted medical treatment. This is only the beginning THE FIRST STEP – and there is still an immense amount of work to be done….

  •  Methadone Awareness Test – Answer Seven

    Admin 08/01/2021

    FALSE!   Extensive research has demonstrated that stabilized methadone maintenance patients are indistinguishable from control groups in cognitive functioning and motor skills. Stable MMT patients can not be distinguished from control groups by way of anything short of a toxicological screening. References: Gordon, N.B.: The functional status of the methadone maintained person; In: Simmons, L.R.S….

  • What is NAMA

    Admin 06/14/2023

    NAMA IS COMMITTED TO: Promoting quality methadone maintenance treatment as the most effective modality for the treatment of heroin addiction.  Working to dispel the ignorance regarding MMT which plagues both treatment professionals and the general public.  Fighting discrimination perpetrated against methadone maintenance patients.  Struggling to destigmatize the treatment which has given us back our lives. …